Meros Investment Management LP Decreases Position in InfuSystem Holdings, Inc. (NYSE:INFU)

Meros Investment Management LP cut its holdings in InfuSystem Holdings, Inc. (NYSE:INFU) by 21.0% in the 2nd quarter, HoldingsChannel.com reports. The firm owned 616,138 shares of the company’s stock after selling 164,113 shares during the period. InfuSystem comprises approximately 2.0% of Meros Investment Management LP’s portfolio, making the stock its 23rd largest holding. Meros Investment Management LP’s holdings in InfuSystem were worth $4,208,000 at the end of the most recent quarter.

Other institutional investors have also added to or reduced their stakes in the company. Vanguard Group Inc. grew its holdings in shares of InfuSystem by 1.7% in the first quarter. Vanguard Group Inc. now owns 1,083,730 shares of the company’s stock worth $9,288,000 after purchasing an additional 18,432 shares during the last quarter. Sequoia Financial Advisors LLC purchased a new stake in InfuSystem during the 2nd quarter valued at $272,000. Wasatch Advisors LP boosted its position in InfuSystem by 3.4% during the 4th quarter. Wasatch Advisors LP now owns 846,609 shares of the company’s stock valued at $8,923,000 after buying an additional 27,881 shares during the period. Ranger Investment Management L.P. grew its holdings in InfuSystem by 4.7% in the 4th quarter. Ranger Investment Management L.P. now owns 689,842 shares of the company’s stock worth $7,271,000 after acquiring an additional 30,835 shares during the last quarter. Finally, Bank of New York Mellon Corp increased its position in shares of InfuSystem by 6.1% in the second quarter. Bank of New York Mellon Corp now owns 93,899 shares of the company’s stock valued at $641,000 after acquiring an additional 5,391 shares during the period. 71.13% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

INFU has been the topic of several recent analyst reports. StockNews.com raised InfuSystem from a “buy” rating to a “strong-buy” rating in a research note on Friday, September 20th. B. Riley assumed coverage on InfuSystem in a report on Thursday. They issued a “buy” rating and a $13.00 price objective for the company.

InfuSystem Stock Up 10.2 %

NYSE:INFU opened at $6.57 on Friday. InfuSystem Holdings, Inc. has a 12 month low of $5.74 and a 12 month high of $10.99. The company has a debt-to-equity ratio of 0.64, a current ratio of 2.07 and a quick ratio of 1.64. The stock has a market capitalization of $140.07 million, a PE ratio of -657,000.00 and a beta of 1.46.

InfuSystem (NYSE:INFU) last posted its quarterly earnings data on Thursday, August 8th. The company reported $0.03 earnings per share for the quarter, missing the consensus estimate of $0.04 by ($0.01). InfuSystem had a net margin of 0.28% and a return on equity of 0.70%. The firm had revenue of $33.70 million for the quarter.

InfuSystem Profile

InfuSystem Holdings, Inc, through its subsidiaries, provides infusion pumps, and related products and services in the United States and Canada. The company operates in two segments, Patient Services and Device Solutions. It supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology, infusion, and hospital outpatient chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states.